Storia in 2 fonti

Obesity drug semaglutide fails to slow Alzheimer's

There were initial hopes that the drug in weight loss jab Wegovy could slow progression of dementia.

Raccontata da

cnbc.com

bbc.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

bbc.comStai leggendo7 mesi fa

Obesity drug semaglutide fails to slow Alzheimer's

There were initial hopes that the drug in weight loss jab Wegovy could slow progression of dementia.

originale

cnbc.com7 mesi fa

Novo Nordisk shares plunge 10% after Alzheimer's drug trial fails to hit key target

Shares of Novo Nordisk plunged after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer's disease failed to meet its main goal.

Leggi questa versione → originale

Timeline cronologica

lunedì 24 novembre 2025·cnbc.com
Novo Nordisk shares plunge 10% after Alzheimer's drug trial fails to hit key target
Shares of Novo Nordisk plunged after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer's disease failed to meet its main goal.
lunedì 24 novembre 2025·bbc.com
Obesity drug semaglutide fails to slow Alzheimer's
There were initial hopes that the drug in weight loss jab Wegovy could slow progression of dementia.